| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.32 | 7e-20 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.28 | 9e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |